Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis

Abstract AKI has a high mortality rate, may lead to chronic kidney disease, and effective therapies are lacking. Micro-RNAs (miRNAs) regulate biologic processes by potently inhibiting protein expression, and pre-clinical studies have explored their roles in AKI. We conducted a systematic review and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sarah Zankar, Mayra Trentin-Sonoda, Jose L. Viñas, Rosendo A. Rodriguez, Adrian Bailey, David Allan, Kevin D. Burns
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/934689081d0644ea8ebe3c6a87dec35c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:934689081d0644ea8ebe3c6a87dec35c
record_format dspace
spelling oai:doaj.org-article:934689081d0644ea8ebe3c6a87dec35c2021-12-02T17:14:58ZTherapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis10.1038/s41598-021-88746-y2045-2322https://doaj.org/article/934689081d0644ea8ebe3c6a87dec35c2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88746-yhttps://doaj.org/toc/2045-2322Abstract AKI has a high mortality rate, may lead to chronic kidney disease, and effective therapies are lacking. Micro-RNAs (miRNAs) regulate biologic processes by potently inhibiting protein expression, and pre-clinical studies have explored their roles in AKI. We conducted a systematic review and meta-analysis of miRNAs as therapeutics in pre-clinical AKI. Study screening, data extraction, and quality assessments were performed by 2 independent reviewers. Seventy studies involving 42 miRNA species were included in the analysis. All studies demonstrated significant effects of the miRNA intervention on kidney function and/or histology, with most implicating apoptosis and phosphatase and tensin homolog (PTEN) signaling. Fourteen studies (20.0%) examined the effect of miRNA-21 in AKI, and meta-analysis demonstrated significant increases in serum creatinine and kidney injury scores with miR-21 antagonism and pre-conditioning. No studies reported on adverse effects of miRNA therapy. Limitations also included lack of model diversity (100% rodents, 61.4% ischemia–reperfusion injury), and predominance of male sex (78.6%). Most studies had an unclear risk of bias, and the majority of miRNA-21 studies were conducted by a single team of investigators. In summary, several miRNAs target kidney function and apoptosis in pre-clinical AKI models, with data suggesting that miRNA-21 may mediate protection and kidney repair. Systematic review registration ID: CRD42019128854.Sarah ZankarMayra Trentin-SonodaJose L. ViñasRosendo A. RodriguezAdrian BaileyDavid AllanKevin D. BurnsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sarah Zankar
Mayra Trentin-Sonoda
Jose L. Viñas
Rosendo A. Rodriguez
Adrian Bailey
David Allan
Kevin D. Burns
Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
description Abstract AKI has a high mortality rate, may lead to chronic kidney disease, and effective therapies are lacking. Micro-RNAs (miRNAs) regulate biologic processes by potently inhibiting protein expression, and pre-clinical studies have explored their roles in AKI. We conducted a systematic review and meta-analysis of miRNAs as therapeutics in pre-clinical AKI. Study screening, data extraction, and quality assessments were performed by 2 independent reviewers. Seventy studies involving 42 miRNA species were included in the analysis. All studies demonstrated significant effects of the miRNA intervention on kidney function and/or histology, with most implicating apoptosis and phosphatase and tensin homolog (PTEN) signaling. Fourteen studies (20.0%) examined the effect of miRNA-21 in AKI, and meta-analysis demonstrated significant increases in serum creatinine and kidney injury scores with miR-21 antagonism and pre-conditioning. No studies reported on adverse effects of miRNA therapy. Limitations also included lack of model diversity (100% rodents, 61.4% ischemia–reperfusion injury), and predominance of male sex (78.6%). Most studies had an unclear risk of bias, and the majority of miRNA-21 studies were conducted by a single team of investigators. In summary, several miRNAs target kidney function and apoptosis in pre-clinical AKI models, with data suggesting that miRNA-21 may mediate protection and kidney repair. Systematic review registration ID: CRD42019128854.
format article
author Sarah Zankar
Mayra Trentin-Sonoda
Jose L. Viñas
Rosendo A. Rodriguez
Adrian Bailey
David Allan
Kevin D. Burns
author_facet Sarah Zankar
Mayra Trentin-Sonoda
Jose L. Viñas
Rosendo A. Rodriguez
Adrian Bailey
David Allan
Kevin D. Burns
author_sort Sarah Zankar
title Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
title_short Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
title_full Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
title_fullStr Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
title_full_unstemmed Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
title_sort therapeutic effects of micro-rnas in preclinical studies of acute kidney injury: a systematic review and meta-analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/934689081d0644ea8ebe3c6a87dec35c
work_keys_str_mv AT sarahzankar therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
AT mayratrentinsonoda therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
AT joselvinas therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
AT rosendoarodriguez therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
AT adrianbailey therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
AT davidallan therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
AT kevindburns therapeuticeffectsofmicrornasinpreclinicalstudiesofacutekidneyinjuryasystematicreviewandmetaanalysis
_version_ 1718381273144098816